Leerink Partners analyst David Resinger warned his clients on Sunday that the tariff risks to the industry are ...

Drugmakers are lobbying US president Donald Trump to phase in tariffs on imported pharmaceutical products in hopes of reducing the sting from the charges and to allow time to shift manufacturing, ...